FC

Feng-Jing Chen

LI Lipocine: 14 patents #6 of 12Top 50%
EP Epalex: 6 patents #2 of 7Top 30%
EP Eagle Pharmaceuticals: 5 patents #4 of 16Top 25%
MC Memorial Sloan Kettering Cancer Center: 3 patents #158 of 761Top 25%
CU Cornell University: 3 patents #259 of 1,984Top 15%
BO BOE: 2 patents #5,928 of 12,373Top 50%
DE Dendreon: 2 patents #47 of 92Top 55%
Stanford University: 1 patents #2,251 of 5,197Top 45%
CM Curators Of The University Of Missouri: 1 patents #512 of 1,157Top 45%
UK University Of Hong Kong: 1 patents #170 of 561Top 35%
BG Beijing Shenogen Pharma Group: 1 patents #5 of 22Top 25%
Overall (All Time): #87,307 of 4,157,543Top 3%
37
Patents All Time

Issued Patents All Time

Showing 25 most recent of 37 patents

Patent #TitleCo-InventorsDate
12397006 Fospropofol formulations Steven L. Krill 2025-08-26
12377110 Fospropofol methods and compositions Steven L. Krill, Michael A. Rogawski, Edward Brendan Magrab, Allen H. Heller 2025-08-05
12370199 Fulvestrant formulations and methods of their use Steven L. Krill, Rama Abu Shmeis 2025-07-29
12268742 Nanotherapeutic systems and methods using particle-driven photodynamic therapy (PDT) Michelle S. Bradbury, Ulrich Wiesner, Snehal G. Patel, Brian Madajewski, Daniella Karassawa Zanoni 2025-04-08
12186427 Fulvestrant formulations and methods of their use Steven L. Krill, Rama Abu Shmeis, Adrian HEPNER, Charles Wescott, Tara Jaskowski +1 more 2025-01-07
12115164 Pemetrexed formulations Steven L. Krill 2024-10-15
11957760 Folate receptor targeted nanoparticle drug conjugates and uses thereof Kai Ma, Aranapakam Mudumbai Venkatesan, Fei Wu, Melik Z. Turker, Thomas C. Gardinier +3 more 2024-04-16
11793813 Pemetrexed formulations Steven L. Krill 2023-10-24
11744897 Folate receptor targeted nanoparticle drug conjugates and uses thereof Kai Ma, Aranapakam Mudumbai Venkatesan, Fei Wu, Melik Z. Turker, Thomas C. Gardinier +3 more 2023-09-05
11628178 Fospropofol methods and compositions Steven L. Krill, Michael A. Rogawski, Edward Brendan Magrab, Allen H. Heller 2023-04-18
11590077 Fulvestrant formulations and methods of their use Steven L. Krill, Rama Abu Shmeis, Adrian HEPNER, Charles Wescott, Tara Jaskowski +1 more 2023-02-28
11559591 Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof Michelle S. Bradbury, Ulrich Wiesner, Kai Ma 2023-01-24
11478490 Fospropofol formulations Steven L. Krill 2022-10-25
11439653 Fospropofol formulations Steven L. Krill 2022-09-13
11207334 Fospropofol formulations Steven L. Krill 2021-12-28
10548989 Nanoparticle immunoconjugates Michelle S. Bradbury, Thomas P. Quinn, Barney Yoo, Jason S. Lewis, Ulrich Wiesner +1 more 2020-02-04
10233249 Antibodies and methods for treating estrogen receptor-associated diseases Xueming Qian, Kun Meng, Xiao Shang, Jing Wang, Lu Li +1 more 2019-03-19
9034831 Pharmaceutical composition for a hepatitis C viral protease inhibitor Robert J. Schwabe 2015-05-19
8460704 Extended release formulation of nevirapine Michael L. Cappola, Svetlana Sienkiewicz, Glenn Charles Snow 2013-06-11
8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression Sateesh Natarajan, Ofir Moreno, Thomas Graddis, David F. Duncan, Reiner Laus 2013-03-05
8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression Sateesh Natarajan, Ofir Moreno, Thomas Graddis, David F. Duncan, Reiner Laus 2013-01-29
7605135 Baicalin as a treatment for SARS infection Kwok Yung Yuen, Kwok Hung Chan, Yi Tsun Richard Kao, Yi Guan, Leo Lit Man Poon +1 more 2009-10-20
7374779 Pharmaceutical formulations and systems for improved absorption and multistage release of active agents Srinivasan Venkateshwaran, Steven L. Krill, Mahesh V. Patel 2008-05-20
7323439 Methods and compositions for modulating angiogenesis Gerald R. Crabtree, Isabella A. Graef 2008-01-29
6982281 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs Mahesh V. Patel 2006-01-03